[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"myelodysplastic-myeloproliferative-diseases\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:myelodysplastic-myeloproliferative-diseases":115},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,56,82],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":41,"overallStatus":43,"whyStopped":4,"lastUpdateSubmitDate":44,"lastUpdatePostDateStruct":45,"startDateStruct":48,"completionDateStruct":50,"leadSponsor":52,"locationsCount":55},"100513772",false,"NCT05969821","Clonal Hematopoiesis of Immunological Significance","Immuno-inflammatory Manifestations With or Without Clonal Hematopoiesis: Ambispective Cohort Study","CHIS","Inclusion Criteria:\n\n* Age \\>=18 years old;\n* Confirmed dysimmune manifestations: clinical or biological abnormality or systemic disease;\n* Presence or absence of myeloid or lymphoid blood disease according to World Health Organization (WHO) classification\n\nExclusion Criteria:\n\n* Persons benefiting from special protection: adults under guardianship and curatorship;\n* People hospitalized without their consent and not protected by law; persons deprived of liberty;\n* Persons not affiliated to the social security system","ALL","18 Years",{"count":19,"type":20},5000,"ESTIMATED","10 Years","OBSERVATIONAL","Ambispective, national, multicenter observational cohort study aimed at characterizing the satellite dysimmune manifestations of clonal hematopoiesis, including Vexas (Vacuoles, E1 enzyme, X-linked, Autoinflammatory and Somatic) syndrome.",[25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40],"Immune System Diseases","Autoimmune Diseases","Inflammation","Autoinflammatory Diseases","Vexas Syndrome","Hematopoiesis Clonal","Clonal Hematopoiesis of Indeterminate Potential","Hematologic Diseases","Myelodysplastic-Myeloproliferative Diseases","Leukemia Myelomonocytic Chronic","Myelodysplastic Syndromes","Myeloproliferative Disorders","Lymphoproliferative Disorders","Lymphoma","Leukemia","Monoclonal Gammopathy of Undetermined Significance",[27,28,42,26,31,33,37,40],"Vexas syndrome","NOT_YET_RECRUITING","2026-03-19",{"date":46,"type":47},"2026-03-23","ACTUAL",{"date":49,"type":20},"2026-04",{"date":51,"type":20},"2045-09",{"name":53,"class":54},"Assistance Publique - Hôpitaux de Paris","OTHER",1,{"id":57,"slug":4,"hasResults":10,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":61,"eligibilityCriteria":62,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":63,"enrollmentInfo":64,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":66,"conditions":67,"keywords":68,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":81},"100271118","NCT02808858","Italian Network MDS Registry","Rete Italiana Dei Registri Regionali Delle Sindromi Mielodisplastiche (MDS)","FISM_registry","Inclusion Criteria:\n\n* New diagnosis of MDS\n\nExclusion Criteria:\n\n* Patient who refuse the signature of informed consent","106 Years",{"count":65,"type":20},10000,"Epidemiological data collection of adult patients affected by myelodysplastic syndrome (MDS) newly diagnosed.",[33],[69,70],"MDS","Myelodisplastic Syndrome","RECRUITING","2025-02-27",{"date":74,"type":47},"2025-03-04",{"date":76,"type":4},"2013-09",{"date":78,"type":20},"2032-05",{"name":80,"class":54},"Fondazione Italiana Sindromi Mielodisplastiche-ETS",20,{"id":83,"slug":4,"hasResults":10,"nctId":84,"briefTitle":85,"officialTitle":86,"acronym":4,"eligibilityCriteria":87,"healthyVolunteers":10,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":88,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":89,"conditions":90,"keywords":100,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":106,"lastUpdatePostDateStruct":107,"startDateStruct":109,"completionDateStruct":111,"leadSponsor":113,"locationsCount":55},"100267393","NCT02760238","Myeloproliferative Neoplasms (MPNs) Patient Registry","Clinical and Molecular Epidemiology of Myeloproliferative Neoplasms (MPNs)","Inclusion Criteria:\n\nDiagnosis of one of the following myeloproliferative neoplasms (MPNs):\n\n* Atypical CML (aCML)\n* Chronic eosinophilic leukemia-not otherwise specified (CEL, NOS),\n* Chronic myelomonocytic leukemia (CMML)\n* Chronic neutrophilic leukemia (CNL),\n* Essential thrombocythemia (ET),\n* Juvenile myelomonocytic leukemia (JMML),\n* Mastocytosis, MPN unclassifiable\n* MPN\u002FMDS unclassifiable,\n* Primary myelofibrosis (PMF),\n* Post-essential thrombocythemia myelofibrosis (post-ET MF),\n* Post-polycythemia vera MF (post-PV MF)\n* Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T)\n\nExclusion Criteria:\n\n* None",{"count":19,"type":20},"The mandate of this MPN registry is to collect clinical information, including molecular results, from consenting patients with a variety of MPNs at different time points during the course of their disease.",[91,92,93,94,95,96,97,33,98,99],"Primary Myelofibrosis","Polycythemia Vera","Essential Thrombocythemia","Mastocytosis","Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative","Leukemia, Myelomonocytic, Juvenile","Chronic Eosinophilic Leukemia-not Otherwise Specified","Neoplasms","Leukemia, Myelomonocytic, Chronic",[101,102,103,104,105,32,98],"myeloproliferative neoplasm","myelodysplastic syndrome","registry","leukemia","Bone Marrow Diseases","2024-08-26",{"date":108,"type":47},"2024-08-27",{"date":110,"type":4},"2015-04",{"date":112,"type":20},"2027-10-31",{"name":114,"class":54},"University Health Network, Toronto",""]